Mouse neurotoxicity test for vaccinia-based smallpox vaccines

Vaccine

Volumn 22, Issue 11-12, 2004, Pages 1486-1493

  Li, Zhongqi ^a   Rubin, Steven A ^a   Taffs, Rolf E ^a   Merchlinsky, Michael ^a   Ye, Zhiping ^a   Carbone, Kathryn M ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Neurotoxicity; Smallpox vaccine; Vaccinia virus

Indexed keywords

SMALLPOX VACCINE; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BIOLOGICAL WARFARE; CONTROLLED STUDY; DRUG APPROVAL; DRUG DETERMINATION; ERADICATION THERAPY; INFECTION CONTROL; MOUSE; MOUSE STRAIN; NERVE CELL; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALLPOX; SMALLPOX VIRUS; TOXICITY TESTING; VACCINATION; VACCINIA; VACCINIA VIRUS; VIRUS REPLICATION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BRAIN; BRAIN CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MICE; MYELIN SHEATH; NERVOUS SYSTEM DISEASES; NEURONS; PLAQUE ASSAY; SMALLPOX VACCINE; SURVIVAL ANALYSIS; VACCINIA; VACCINIA VIRUS; VIRUS REPLICATION;

EID: 1842561456     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.10.022     Document Type: Article

References (31)

1. Buller R.M., Palumbo G.J. Poxvirus pathogenesis. Microbiol. Rev. 55(1):1991;80-122.
2. Moss B. Vaccinia virus: a tool for research and vaccine development. Science. 252:1991;1662-1667.
3. Piccini A., Paoletti E. Vaccinia: virus, vector, vaccine. Adv. Virus Res. 34:1988;43-64.
4. Goldstein J.A., Neff J.M., Lane J.M., Koplan J.P. Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics. 55(3):1975;342-347.
5. Gurvich E.B., Vilesova I.S. Vaccinia virus in postvaccinial encephalitis. Acta Virol. 27:1983;154-159.
6. Rockoff A., Spigland I., Lorenstein B., Rose A.L. Postvaccinial encephalomyelitis without cutaneous vaccination reaction. Ann. Neurol. 5(1):1979;99-101.
7. Henderson DA, Moss B, Smallpox and vaccinia. In: Plotkin SA, Orenstein WA, editors. Vaccines. Philadelphia: W.B. Saunders Company; 1999. p. 74-97.
8. Romanov V.A., Bereshkova R.V. Zh. Mikrobiol. Epidemiol. Immunobiol. 6:1975;66-72.
9. Edwards K.M., Andrews T.C., Van Savage J., Palmer P.S., Moyer R.W. Poxvirus deletion mutants: virulence and immunogenicity. Microb. Pathogen. 4(5):1988;325-333.
10. World Health Organization. Requirements for biological substances: requirements for smallpox vaccine. WHO Tech. Rep. 1966;Ser. 323:56-71.
11. Rosenthal S.R., Merchlinsky M., Kleppinger C., Goldenthal K.L. Developing new smallpox vaccines. Emerg. Infect. Dis. 7:2001;920-926.
12. World Health Organization. Advisory Committee on Variola Virus Research: Report of a WHO meeting. WHO/CDS/CSR/2000; 2000. p. 1:1-18.
13. Tscharke D.C., Smith G.L. A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. J. Gen. Virol. 80(Pt 10):1999;2751-2755.
14. Ludvikova V., Kutinova L., Simonova V., Otavova M. Evaluation of various virulence test with low virulence vaccinia virus in mice. Biologicals. 22:1994;187-190.
15. Dzagurov S.G., Gurvich E.B., Ozeretskovskii N.A. Results of a study of the pathogenesis of postvaccinal encephalitis. Vopr. Virusol. 4:1981;398-404.
16. Li X.Q., Itoh M., Yano A., Miyamoto K., Takeuchi Y. Immunohistochemical detection of testicular macrophages during the period of postnatal maturation in the mouse. Int. J. Androl. 21(6):1998;370-376.
17. Ginsberg A.H., Johnson K.P. Vaccinia virus meningitis in mice after intracerebral inoculation. Infect. Immun. 13:1976;1221-1227.
18. Kristensson K., Sourander P. Changes in vascular permeability of the central nervous system by experimental herpes simplex and vaccinia virus infections. Acta Neuropathol. (Berl.). 14(1):1969;38-51.
19. Morita M., Arita M., Komatsu T., Amano H., Hashizume S. A comparison of neurovirulence of vaccinia virus by intrathalamic and/or intracisternal inoculations into cynomolgus monkeys. Microbiol. Immunol. 21(7):1977;417-418.
20. Simon J., Werner G.T. Vaccinia virus infection of the central nervous system in X-irradiated mice. Infect. Immun. 25(3):1979;1035-1042.
21. Rubin S.A., Bautista J.R., Moran T.H., Schwartz G.J., Carbone K.M. Viral teratogenesis: brain developmental damage associated with maturation state at the time of infection. Dev. Brain Res. 112:1999;237-244.
22. Soekawa M., Morita C., Moriguchi R., Nakamura M. Neurovirulence of vaccinia viruses for mice. Zentralbl. Bakteriol. [Orig A]. 226(4):1974;434-442.
23. Blinzinger K., Hochstein-Mintzel V., Anzil A.P. Experimental vaccinia virus meningoencephalitis in adult albino mice: virological, light microscopic and ultrastructural studies. Acta Neuropathol. (Berl.). 40(3):1977;193-205.
24. Davis L.E. Communicating hydrocephalus in newborn hamsters and cats following vaccinia virus infection. J. Neurosurg. 54:1981;767-772.
25. Morishima T., Hayashi K. Meningeal exudate cells in vaccinia meningitis of mice: role of local T cells. Infect. Immun. 20(3):1978;752-759.
26. Werner G.T., Jentzch U., Metzger E., Simon J. Studies on poxvirus infections in irradiated animals. Arch. Virol. 64:1980;247-256.
27. Murphy F.A., Harrison A.K., Gary G.W. Jr., Whitfield S.G., Forrester F.T. St. Louis encephalitis virus infection in mice. Electron microscopic studies of central nervous system. Lab. Invest. 19(6):1968;652-662.
28. Beranek C.F., Schafer R., Bologa L., Herschkowitz N. Viral tropisms in mouse brain cell cultures. Med. Microbiol. Immunol. 170:1982;201-207.
29. Kristensson K., Hansson H.A., Sourander P. Observation on cultures of rabbit infected with vaccinia and herpes simplex virus. J. Gen. Virol. 6:1970;41-49.
30. Simon J., Werner G.T. Vaccinia infection of the nervous system in animals with normal and altered immune reaction. Acta Neuropathol. Suppl. (Berl.). 7:1981;147-149.
31. Lee M.S., Roos J.M., McGuigan L.C., Smith K.A., Cormier N., Cohen L.K.et al. Molecular attenuation of vaccinia virus: mutant generation and animal characterization. J. Virol. 66:1992;2617-2630.